Skip to content
CVE Ledger
  • Newest CVEsPage
  • Recently added to KEVPage
  • Rising exploitation (EPSS)Page
  • Weekly digestPage
  • StatisticsPage
  • WatchlistPage
  • API docsPage
  • MCP serverPage
  • AboutPage
  • Data sourcesPage
  • Data statusPage
  • ChangelogPage
  • How it's builtPage
  • Support the projectPage

14 results

Back

CVE-2022-37461Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject…

Description

Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3) offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.

Timeline

  1. ID reserved

    By mitre

  2. · 54 days later

    Published

  3. · 3 years later

    Record updated

Changes after publication (a new score, a public exploit, EPSS crossing 1, 10 or 50 %, leaving KEV) are kept since November 2026; earlier ones are not known.

Scores

CVSS scores of CVE-2022-37461, by who scored it
Scored byCVSSScoreVector
CISA-ADPADP (enrichment)3.1Medium6.1CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
NVDNVD · Modified3.1Medium6.1CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
EPSS (exploitation in 30 days)
1.1% · top 34% of all CVEs (15 Nov 2026)
CISA SSVC
Exploitation: none · Automatable: no · Technical impact: total
Loading the EPSS history…

The list uses the assigner's score when there is one, then CISA's, then NVD's: Medium 6.1.

Affected products

  • n/a

    • affected n/a

References

References3

Sources

The same CVE in the primary databases and aggregators, to check against.

Badge for a README or a ticket

CVE-2022-37461 badge
[![CVE-2022-37461](https://cveledger.app/badge/CVE-2022-37461.svg)](https://cveledger.app/cve/CVE-2022-37461)

Record last updated .